These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 2568832)

  • 1. P-glycoprotein gene (MDR1) cDNA from human adrenal: normal P-glycoprotein carries Gly185 with an altered pattern of multidrug resistance.
    Kioka N; Tsubota J; Kakehi Y; Komano T; Gottesman MM; Pastan I; Ueda K
    Biochem Biophys Res Commun; 1989 Jul; 162(1):224-31. PubMed ID: 2568832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An altered pattern of cross-resistance in multidrug-resistant human cells results from spontaneous mutations in the mdr1 (P-glycoprotein) gene.
    Choi KH; Chen CJ; Kriegler M; Roninson IB
    Cell; 1988 May; 53(4):519-29. PubMed ID: 2897240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular basis of preferential resistance to colchicine in multidrug-resistant human cells conferred by Gly-185----Val-185 substitution in P-glycoprotein.
    Safa AR; Stern RK; Choi K; Agresti M; Tamai I; Mehta ND; Roninson IB
    Proc Natl Acad Sci U S A; 1990 Sep; 87(18):7225-9. PubMed ID: 1976255
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of residues in the first cytoplasmic loop of P-glycoprotein involved in the function of chimeric human MDR1-MDR2 transporters.
    Currier SJ; Kane SE; Willingham MC; Cardarelli CO; Pastan I; Gottesman MM
    J Biol Chem; 1992 Dec; 267(35):25153-9. PubMed ID: 1360983
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multidrug resistance in cells transfected with human genes encoding a variant P-glycoprotein and glutathione S-transferase-pi.
    Fairchild CR; Moscow JA; O'Brien EE; Cowan KH
    Mol Pharmacol; 1990 Jun; 37(6):801-9. PubMed ID: 1972772
    [TBL] [Abstract][Full Text] [Related]  

  • 6. mdr1/P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profiles.
    Gekeler V; Weger S; Probst H
    Biochem Biophys Res Commun; 1990 Jun; 169(2):796-802. PubMed ID: 1972623
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Functional consequences of glycine mutations in the predicted cytoplasmic loops of P-glycoprotein.
    Loo TW; Clarke DM
    J Biol Chem; 1994 Mar; 269(10):7243-8. PubMed ID: 7907326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutation of glycine 185 to valine alters the ATPase function of the human P-glycoprotein expressed in Sf9 cells.
    Rao US
    J Biol Chem; 1995 Mar; 270(12):6686-90. PubMed ID: 7896810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarized expression of P-glycoprotein in MDCK cells.
    Pastan I; Gottesman MM; Ueda K; Lovelace E; Rutherford AV; Willingham MC
    Proc Natl Acad Sci U S A; 1988 Jun; 85(12):4486-90. PubMed ID: 2898143
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two members of the mouse mdr gene family confer multidrug resistance with overlapping but distinct drug specificities.
    Devault A; Gros P
    Mol Cell Biol; 1990 Apr; 10(4):1652-63. PubMed ID: 1969610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The mdr1 gene, responsible for multidrug-resistance, codes for P-glycoprotein.
    Ueda K; Cornwell MM; Gottesman MM; Pastan I; Roninson IB; Ling V; Riordan JR
    Biochem Biophys Res Commun; 1986 Dec; 141(3):956-62. PubMed ID: 2880583
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA.
    Lincke CR; van der Bliek AM; Schuurhuis GJ; van der Velde-Koerts T; Smit JJ; Borst P
    Cancer Res; 1990 Mar; 50(6):1779-85. PubMed ID: 1968359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. N-glycosylation and deletion mutants of the human MDR1 P-glycoprotein.
    Schinkel AH; Kemp S; Dollé M; Rudenko G; Wagenaar E
    J Biol Chem; 1993 Apr; 268(10):7474-81. PubMed ID: 8096511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Discrete mutations introduced in the predicted nucleotide-binding sites of the mdr1 gene abolish its ability to confer multidrug resistance.
    Azzaria M; Schurr E; Gros P
    Mol Cell Biol; 1989 Dec; 9(12):5289-97. PubMed ID: 2573836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of the MDR1 (P-glycoprotein) gene in multidrug resistance in vitro and in vivo.
    Roninson IB
    Biochem Pharmacol; 1992 Jan; 43(1):95-102. PubMed ID: 1346497
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cleavage of human MDR1 mRNA by a hammerhead ribozyme.
    Kobayashi H; Dorai T; Holland JF; Ohnuma T
    FEBS Lett; 1993 Mar; 319(1-2):71-4. PubMed ID: 8095909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulatory effects on substrate specificity of independent mutations at the serine939/941 position in predicted transmembrane domain 11 of P-glycoproteins.
    Dhir R; Grizzuti K; Kajiji S; Gros P
    Biochemistry; 1993 Sep; 32(36):9492-9. PubMed ID: 8103679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A single amino acid substitution strongly modulates the activity and substrate specificity of the mouse mdr1 and mdr3 drug efflux pumps.
    Gros P; Dhir R; Croop J; Talbot F
    Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7289-93. PubMed ID: 1678520
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Altered activity of MDR-reversing agents on KB3-1 cells transfected with Gly(185)-->Val human P-glycoprotein.
    Watanabe T; Uchiyama N; Roninson IB; Cohen D; Atadja P
    Int J Oncol; 2000 Sep; 17(3):579-86. PubMed ID: 10938401
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Deletion and insertion mutants of the multidrug transporter.
    Currier SJ; Ueda K; Willingham MC; Pastan I; Gottesman MM
    J Biol Chem; 1989 Aug; 264(24):14376-81. PubMed ID: 2569468
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.